Advanced Glycation End Products as Environmental Risk Factors for the Development of Type 1 Diabetes
Journal:
Current Drug Targets
Volume:
13
Page:
526-540
Author(s):
Felicia Y.T. Yap, Phillip Kantharidis, Melinda T. Coughlan, Robyn Slattery and Josephine M. Forbes
Clinical Update on the Use of Immuno Modulators (antiCD3, GAD, Diapep277, Anti-IL1) in Type 1 Diabetes
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3224-3228
Author(s):
Paolo Pozzilli, Chiara Guglielmi, Daria Maggi, Angela Carlone, Raffaella Buzzetti and Silvia Manfrini
Autoimmune Diabetes Mellitus: The Importance of Autoantibodies for Disease Prediction and Diagnostic Support
Journal:
Current Immunology Reviews (Discontinued)
Volume:
6
Page:
299-313
Author(s):
Silvina Noemi Valdez and Edgardo Poskus*
A Proposal for a New Classification of Type 1 Diabetes Mellitus Based on Clinical and Immunological Evidence
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
3
Page:
54-59
Author(s):
Masahito Katahira
Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms
Journal:
Current Genomics
Volume:
9
Page:
324-337
Author(s):
Peng Gao, Yan Jiao, Qing Xiong, Cong-Yi Wang, Ivan Gerling and Weikuan Gu
Sepsis: Links between Pathogen Sensing and Organ Damage
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1840-1852
Author(s):
Elliott Crouser, Matthew Exline, Daren Knoell and Mark D. Wewers
Candidate Genes Implicated in Type 1 Diabetes Susceptibility
Journal:
Current Diabetes Reviews
Volume:
4
Page:
110-121
Author(s):
Mourad Aribi
Omega-3 Fatty Acids for Nutrition and Medicine: Considering Microalgae Oil as a Vegetarian Source of EPA and DHA
Journal:
Current Diabetes Reviews
Volume:
3
Page:
198-203
Author(s):
Scott D. Doughman, Srirama Krupanidhi and Carani B. Sanjeevi
Reactive Species, Cellular Repair and Risk Factors in the Onset of Type 2 Diabetes Mellitus: Review and Hypothesis
Journal:
Current Diabetes Reviews
Volume:
2
Page:
241-259
Author(s):
Leonid E. Fridlyand and Louis H. Philipson
Targeting Type 1 Diabetes Before and at the Clinical Onset of Disease
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
103-124
Author(s):
L. M. Bekris, T. J. Kavanagh and A. Lernmark